<!doctype html public "-//W3C//DTD W3 HTML//EN">
<html><head><style type="text/css"><!--
blockquote, dl, ul, ol, li { padding-top: 0 ; padding-bottom: 0 }
 --></style><title>COST B22 &quot;Drug Development for Parasitic
Diseases&quot; Nov 22-</title></head><body>
<div><font face="Arial" size="+1" color="#000000"><b>Second
announcement:</b></font></div>
<div><font face="Arial" size="+2"
color="#000000"><b><br></b></font></div>
<div><font face="Arial" size="+2" color="#000000"><b>International
Congress on &quot;Drug Development for Parasitic
Diseases&quot;</b></font></div>
<div><font face="Arial" size="+2"
color="#000000"><b><br></b></font></div>
<div><font face="Arial" size="+2" color="#000000"><b>Organized by COST
Action B22 and the Institute of Tropical Medicine, Antwerp, Belgium,
November 22-24, 2004
(http://www.icp.be/costb22/antwerp/)</b></font></div>
<div><font face="Arial" size="+2"
color="#000000"><b><br></b></font></div>
<div><font face="Arial" size="+2" color="#000000"><b>with sessions on
the following topics:</b></font></div>
<div><font face="Arial" size="-3" color="#000000"><b>Exploiting the
genome</b></font></div>
<div><font face="Arial" size="-3" color="#000000"><b>Drug evaluation
(in vitro and in vivo)</b></font></div>
<div><font face="Arial" size="-3" color="#000000"><b>Pre-clinical
development</b></font></div>
<div><font face="Arial" size="-3" color="#000000"><b>Drug
resistance</b></font></div>
<div><font face="Arial" size="-3" color="#000000"><b>Drugs: role of
the public sector. Joint session with DNDi</b></font></div>
<div><font face="Arial" size="-3"
color="#000000"><i><b><br></b></i></font></div>
<div><font face="Arial" size="-3" color="#000000"><b>With poster
presentations</b></font></div>
<div><font face="Arial" size="-3"
color="#000000"><i><b><br></b></i></font></div>
<div><font face="Arial" size="-3" color="#000000">Deadline for
abstract submission : Friday 1 October, 2004</font></div>
<div><font face="Arial" size="-3" color="#000000">Participants will be
informed about the acceptance of their abstract: 18 October,
2004</font></div>
<div><font face="Arial" size="-3" color="#000000">Deadline for&nbsp;
registration : 1 November 2004</font><font face="Arial" size="+1"
color="#000000"> &nbsp;</font></div>
<div><font face="Arial" size="+1" color="#000000"><br></font></div>
<div><font face="Arial" size="+1" color="#000000">Registration
preferably via our website:<b>
http://www.icp.be/costb22/antwerp/</b></font></div>
<div><font face="Arial" size="+1" color="#000000"><br></font></div>
<div><font face="Arial" size="-3" color="#000000"><b>Sponsored
by:</b></font><font face="Arial" size="-3" color="#0000FF"><b>
International&nbsp; Organization for Chemical Sciences in Development
(IOCD), COST and the Commission&nbsp; of the European&nbsp; Union,
Merial, Tibotec, Fortis Bank</b></font></div>
<div><br></div>
<x-sigsep><pre>-- 
</pre></x-sigsep>
<div>Prof. Fred R. Opperdoes<br>
Chairman EU COST Action B22 &quot;Drug development for parasitic
diseases&quot; (http://www.icp.be/cost/costB22/)<br>
<br>
Tel: ++32-2-764.74.39 (secretary) Fax: ++32-2-762.68.53<br>
Tel: ++32-2-764.74.55 (direct)<br>
E-mail: Opperdoes@bchm.ucl.ac.be</div>
</body>
</html>